Introducing a novel approach to enhance checkpoint inhibitor therapy for cancer, promising improved treatment outcomes and efficacy in clinical...
Vous n'êtes pas connecté
Checkpoint inhibitor therapies release the immune system's molecular "brakes," removing protein barriers that hinder its ability to detect and attack cancer cells.
Introducing a novel approach to enhance checkpoint inhibitor therapy for cancer, promising improved treatment outcomes and efficacy in clinical...
Researchers at the University of Turku in Finland have found a new function for an existing protein. They discovered that TIMP-1, a protein...
Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung...
HER2-positive breast cancer, known for its aggressive nature due to the overexpression of the HER2 protein, poses significant challenges in treatment....
Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung...
A paper published in May in the American Gastroenterological Association journalCellular and Molecular Gastroenterology and Hepatology focusses on...
Breast cancer is a complex disease with varying degrees of severity and treatment approaches. Central to understanding and managing breast cancer is...
Researchers at Karolinska Institutet in Sweden have developed nanorobots that kill cancer cells in mice.
Tiny particles of gold, just a billionth of a meter in size, have been known to kill cancer cells for a long time. It was thought that the smaller the...
Artificial intelligence (AI) may help doctors to detect and diagnose cancer in patients that will allow for earlier treatment, reports a new study. ...